JP2021523134A5 - - Google Patents

Info

Publication number
JP2021523134A5
JP2021523134A5 JP2020562568A JP2020562568A JP2021523134A5 JP 2021523134 A5 JP2021523134 A5 JP 2021523134A5 JP 2020562568 A JP2020562568 A JP 2020562568A JP 2020562568 A JP2020562568 A JP 2020562568A JP 2021523134 A5 JP2021523134 A5 JP 2021523134A5
Authority
JP
Japan
Prior art keywords
group
indazole
alkyl
carboxamide
compound according
Prior art date
Application number
JP2020562568A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019215075A5 (https=
JP7411574B2 (ja
JP2021523134A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/061532 external-priority patent/WO2019215075A1/en
Publication of JP2021523134A publication Critical patent/JP2021523134A/ja
Publication of JPWO2019215075A5 publication Critical patent/JPWO2019215075A5/ja
Publication of JP2021523134A5 publication Critical patent/JP2021523134A5/ja
Application granted granted Critical
Publication of JP7411574B2 publication Critical patent/JP7411574B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020562568A 2018-05-07 2019-05-06 グリコーゲンシンターゼキナーゼ３ベータ阻害剤としての１ｈ－インダゾール－３－カルボキサミド化合物 Active JP7411574B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18171084 2018-05-07
EP18171084.9 2018-05-07
PCT/EP2019/061532 WO2019215075A1 (en) 2018-05-07 2019-05-06 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors

Publications (4)

Publication Number Publication Date
JP2021523134A JP2021523134A (ja) 2021-09-02
JPWO2019215075A5 JPWO2019215075A5 (https=) 2022-03-29
JP2021523134A5 true JP2021523134A5 (https=) 2022-03-29
JP7411574B2 JP7411574B2 (ja) 2024-01-11

Family

ID=62134122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020562568A Active JP7411574B2 (ja) 2018-05-07 2019-05-06 グリコーゲンシンターゼキナーゼ３ベータ阻害剤としての１ｈ－インダゾール－３－カルボキサミド化合物

Country Status (28)

Country Link
US (1) US11472795B2 (https=)
EP (1) EP3790873B1 (https=)
JP (1) JP7411574B2 (https=)
KR (1) KR102778690B1 (https=)
CN (1) CN112135821B (https=)
AU (1) AU2019265606B2 (https=)
BR (1) BR112020021922A2 (https=)
CA (1) CA3094896A1 (https=)
CY (1) CY1125293T1 (https=)
DK (1) DK3790873T3 (https=)
EA (1) EA202092422A1 (https=)
ES (1) ES2913975T3 (https=)
GE (2) GEP20227437B (https=)
HR (1) HRP20220664T1 (https=)
HU (1) HUE058894T2 (https=)
IL (1) IL278330B2 (https=)
LT (1) LT3790873T (https=)
MA (1) MA52557A (https=)
MD (1) MD3790873T2 (https=)
MX (1) MX2020011882A (https=)
PL (1) PL3790873T3 (https=)
PT (1) PT3790873T (https=)
RS (1) RS63255B1 (https=)
SG (1) SG11202009230WA (https=)
SI (1) SI3790873T1 (https=)
SM (1) SMT202200227T1 (https=)
UA (1) UA128089C2 (https=)
WO (1) WO2019215075A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023506257A (ja) * 2019-12-16 2023-02-15 コリア リサーチ インスティチュート オブ ケミカル テクノロジー 新規なインダゾール誘導体及びその用途
CN114230565B (zh) * 2020-09-09 2023-10-27 成都奥睿药业有限公司 5-取代吲哚3-酰胺衍生物及其制备方法和用途
WO2022125377A1 (en) * 2020-12-08 2022-06-16 Disarm Therapeutics, Inc. Benzopyrazole inhibitors of sarm1

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ257545A (en) 1992-11-05 1997-01-29 Smithkline Beecham Plc Heterocyclic (especially piperidine) derivatives and pharmaceutical compositions
GB0218625D0 (en) 2002-08-10 2002-09-18 Astex Technology Ltd Pharmaceutical compounds
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20030972A1 (it) 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
KR101061599B1 (ko) * 2008-12-05 2011-09-02 한국과학기술연구원 비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
TW201040191A (en) 2009-03-27 2010-11-16 Abbott Gmbh & Co Kg Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
EP3473099A1 (en) * 2011-09-14 2019-04-24 Samumed, LLC Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
CA2860250C (en) * 2012-02-21 2020-11-10 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
RS54539B1 (sr) 2012-02-21 2016-06-30 Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A. Upotreba 1h-indazol-3-karboksamidnih jedinjenja kao inhibitora kinaze 3-beta glikogen sintetaze
MX2016012208A (es) * 2014-03-20 2017-01-26 Samumed Llc Indazol-3-carboxamidas 5-substituidas y preparacion y uso de las mismas.
AU2019224075A1 (en) * 2018-02-23 2020-09-10 Samumed, Llc 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof

Similar Documents

Publication Publication Date Title
JP2021523134A5 (https=)
JP2015506993A5 (https=)
PE20110063A1 (es) DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
PE20090297A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogenesis
HRP20160125T1 (hr) Spojevi 1h-indazol-3-karboksamida kao inhibitori glikogen sinteze kinaze-3 beta
MY162413A (en) Novel heterocyclic derivatives and their use in the treatment of neurological disorders
KR20110098854A (ko) 피리다지논 유도체
PE20091849A1 (es) Compuestos y composiciones como inhibidores de cinasa
NZ630467A (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
RU2012134306A (ru) Азотосодержащие производные гетероарилов
JP2020502092A5 (https=)
AR070266A1 (es) Derivados de n-(2-amino-fenil)-amida, una composicion farmaceutica que los contiene y su uso para la fabricacion de un medicamento para el tratamiento del cancer.
NZ601967A (en) Pde10 inhibitors and related compositions and methods
AR077066A1 (es) Derivados de tiazolilpiperidina como fungicidas, procedimientos para su preparacion e intermediarios de sintesis utilizados en los mismos.
AR069595A1 (es) Compuestos amida como refuerzos de antivirales
HRP20160124T1 (hr) Uporaba spojeva 1h-indazol-3-karboksamida kao inhibitora glikogen sinteze kinaze-3 beta
HRP20220664T1 (hr) 1h-indazol-3-karboksamid spojevi kao inhibitori glikogen sintaza kinaze 3 beta
US9975906B2 (en) Tricyclic heterocycle derivatives having HIV replication inhibitory effect
PE20120063A1 (es) Derivados de ciclopropilamida dirigidos contra el receptor de histamina h3
BR112021018578A2 (pt) Compostos de heterociclil(fenil)metanol úteis no tratamento de hiperglicemia
KR20110105848A (ko) 피리다지논 유도체
JP7261793B2 (ja) Ｓｒｐｋ１阻害剤
JP2010529132A5 (https=)
WO2022002270A1 (zh) 一种嘧啶类衍生物及其制备方法和应用
JPWO2019215075A5 (https=)